1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2016-2020 France HIV/AIDS Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500.

Summary

This report presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western Blot,
HTLV-I/II and other confirmatory tests performed in the following market segments:

     - Hospitals
     - Commercial/Private Laboratories
     - Blood Banks

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 7 tables

Table Of Contents

2016-2020 France HIV/AIDS Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
I. Introduction
II. AIDS/HIV Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. Potential Market Entry Barriers and Risks

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatch/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables

Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. France: HIV or HIV-1/2/Combo Test Volume and Sales Forecast by Market Segment
Table 3. France: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast
by Market Segment
Table 5. France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. France: AIDS Diagnostics Market by Major Supplier
Table 7. France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers



View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

AIDS Related Kaposi%s Sarcoma-Market Insights, Epidemiology and Market Forecast-2023 

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s AIDS Related Kaposi’s Sarcoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

HIV-associated Lipodystrophy- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s HIV-associated Lipodystrophy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Analysis By Drug Class (Nucleoside-Analog Reverse Transcriptase Inhibitors, Non-NRTIs, Entry & Fusion, Protease, Integrase Inhibitors, Coreceptor Antagonists), And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • October 2016
  • by Grand View Research

The global HIV-1 therapeutics market is expected to reach a value of USD 15.8 billion by 2025, growing at a CAGR of 1.4%. According to a new report by Grand View Research, Inc., HIV continues to be one ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.